p53 expression and TGF-α-induced replication of hepatocytes isolated from rats exposed to the carcinogen diethylnitrosamine

被引:0
|
作者
P. Lennartsson
U. Stenius
J. Högberg
机构
[1] Institute of Environmental Medicine,
[2] Karolinska Institutet,undefined
[3] National Institute for Working Life,undefined
来源
关键词
diethylnitrosamine; EGF receptor; enzyme-altered foci; hepatocytes; p53; TGF-α;
D O I
暂无
中图分类号
学科分类号
摘要
Previous reports indicate that the expression of transforming growth factor α (TGF-α) is increased in enzyme-altered foci (EAF) arising in livers of rats treated with a carcinogen. Here we have investigated the effects of TGF-α on EAF cells in vitro. Hepatocytes were isolated from rats that had received repeated treatment with diethylnitrosamine (DEN) and whose livers contained glutathione S-transferase P (GST-P)-positive EAF. Primary cultures of GST-P-positive and GST-P-negative hepatocytes were exposed to TGF-α. TGF-α (20–40 ng/ml) increased DNA replication in the GST-P-negative, but not in the GST-P-positive cells. Furthermore, it was shown that this effect on GST-P-negative cells could be blocked by p53 antisense oligonucleotides. We conclude that EAF hepatocytes do not respond to TGF-α in vitro. This lack of response may reflect the attenuated expression of p53 in these cells. These data corroborate previous findings that, in response to DNA damage, many EAF hepatocytes do not accumulate p53.
引用
收藏
页码:31 / 39
页数:8
相关论文
共 50 条
  • [31] Arecoline-induced growth arrest and p21WAF1 expression are dependent on p53 in rat hepatocytes
    Chou, Wen-Wen
    Guh, Jinn-Yuh
    Tsai, Jung-Fa
    Hwang, Chi-Ching
    Chen, Hung-Chun
    Huang, Jau-Shyang
    Yang, Yu-Lin
    Hung, Wen-Chun
    Chuang, Lea-Yea
    TOXICOLOGY, 2008, 243 (1-2) : 1 - 10
  • [32] Absence of p53 Gene Expression in Selenium Molecular Prevention of Chemically Induced Hepatocarcinogenesis in Rats
    Alwahaibi, Nasar Y.
    Budin, Siti B.
    Mohamed, Jamaludin. H.
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2011, 17 (05): : 328 - 334
  • [33] p53 protein expression in peripheral lymphocytes from atrazine chronically intoxicated rats
    Cantemir, C
    Cozmei, C
    Scutaru, B
    Nicoara, S
    Carasevici, E
    TOXICOLOGY LETTERS, 1997, 93 (2-3) : 87 - 94
  • [34] Ki-67, p53, bcl-2, TGF-α and EGF receptor expression in rectal carcinoid tumors.
    Shimizu, T
    Tanaka, S
    Haruma, K
    Tanimoto, T
    Kunihiro, M
    Kimura, T
    Kitadai, Y
    Yosihara, M
    Sumii, K
    Kajiyama, G
    Shimamoto, F
    GASTROENTEROLOGY, 1998, 114 (04) : A1180 - A1180
  • [35] Analysis of K-ras and p53 mutations in mesotheliomas from humans and rats exposed to asbestos
    Ni, ZY
    Liu, YQ
    Keshava, N
    Zhou, G
    Whong, WZ
    Ong, TM
    MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2000, 468 (01) : 87 - 92
  • [36] Fas-mediated apoptosis is attenuated in preneoplastic GST-P-positive hepatocytes isolated from diethylnitrosamine-treated rats
    M. Nordstrand
    U. Stenius
    Cell Biology and Toxicology, 1999, 15 : 239 - 247
  • [37] Fas-mediated apoptosis is attenuated in preneoplastic GST-P-positive hepatocytes isolated from diethylnitrosamine-treated rats
    Nordstrand, M
    Stenius, U
    CELL BIOLOGY AND TOXICOLOGY, 1999, 15 (04) : 239 - 247
  • [38] Mesotheliomas induced in rats by the fibrous mineral erionite are independent from p53 alterations
    Kleymenova, EV
    Horesovsky, G
    Pylev, LN
    Everitt, J
    CANCER LETTERS, 1999, 147 (1-2) : 55 - 61
  • [39] Impaired TGF-β induced growth inhibition contributes to the increased proliferation rate of neural stem cells harboring mutant p53
    Kumar, Praveen
    Naumann, Ulrike
    Aigner, Ludwig
    Wischhusen, Joerg
    Beier, Christoph P.
    Beier, Dagmar
    AMERICAN JOURNAL OF CANCER RESEARCH, 2015, 5 (11): : 3436 - 3445
  • [40] Role of p53 in promoting BMP9-induced osteogenic differentiation of mesenchymal stem cells through TGF-β1
    Yao, Xintong
    Li, Peipei
    Deng, Yixuan
    Yang, Yuanyuan
    Luo, Honghong
    He, Baicheng
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 25 (06)